Journal Logo

Articles by A. Gabrion

RED BLOOD CELLS PROPERTIES IN PATIENTS WITH SICKLE CELL DISEASE TREATED WITH LENTIGLOBIN GENE THERAPY IN THE HGB-205 TRIAL: PF441

Magrin, E.; Semeraro, M.; Hebert, N.; More

HemaSphere. 3:173-174, June 2019.